Martí Jiménez-Mausbach works in Global Medical and Regulatory Affairs at Novo Nordisk in Copenhagen. He has conducted research in Germany, UK, USA and Denmark.
“Only two weeks after detecting the first Covid infection, the government rapidly introduced mobility restrictions, ahead of large European countries. It never introduced full lockdown, however,” says Martí Jiménez-Mausbach. He also highlights the importance of mass testing in the country and the collaboration between the government and Novo Nordisk. Martí Jiménez-Mausbach. Además, también subraya la importancia del testeo masivo y la colaboración entre el gobierno y Novo Nordisk.
As for Barcelona’s handling of the crisis, Jiménez-Mausbach describes it as “unpredictable and confusing”. He also points out that the cancellation of the Orfeu Program “was a missed opportunity, preventing active collaboration with universities, research centers and private laboratories.” Even so, he highlights the undisputed success of the vaccination program that demonstrated the “resilience of the health system and the commitment of citizens.”
Jiménez-Mausbach concludes with three proposals for Barcelona. He suggests (i) institutionalizing the data evaluation and use, essential tools for increasing accountability, trust and democratic quality; (ii) introducing scientific advice and data analysis tools in a systematic manner; (iii) ensuring that knowledge flows in an effective and coordinated way throughout the administration.